National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
ORPHENADRINE CITRATE EXTENDED-RE
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NORFLEX | 04515 | A | 5 | 1 | 4 | KX | ||
| NORFLEX TABLETS | 04515 | A | 5 | 1 | 4 | KX | ||
| NDC00089-0221-10 | 04515 | A | 3 | 2 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 04515 | 3M COMPANY HEALTH CARE/MFG |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT |